Page 309. Corresponding Author: Dr. Nitesh. R. Maurya, Volume 3 Issue - 5, Page No
|
|
- Gladys Walters
- 5 years ago
- Views:
Transcription
1 ISSN- O: X, ISSN P: Index Copernicus Value: PubMed - National Library of Medicine - ID: SJIF Impact Factor: International Journal of Medical Science and Innovative Research (IJMSIR) IJMSIR : A Medical Publication Hub Available Online at: Volume 3, Issue 5, September , Page No. : Inguinal Lymph Node Metastasis Presenting As a Delayed Site Metastasis in a Case of Early Endometrial Carcinoma. Maurya N. R 1, Bhukte S 2. A, Sharma S. D 2, Bhavsar. U. C 3, Kulkarni. J. N 4 1 Department of Gynae-oncology, Asian Cancer Institute, Mumbai, India. 2 Department of Surgical oncology, Asian Cancer Institute, Mumbai, India. 3 Junior Consultant, Sahil Speciality Hospital, Mumbai, India. 4 Prof and Head of Dept. surgical Oncology, Asian Cancer Institute, Mumbai, India. Corresponding Author: Dr. Nitesh. R. Maurya, Department of Gynae-Oncology, Asian Cancer Institute, Sion, Mumbai, India, Type of Publication: Case Report Conflicts of Interest: Nil Abstract Introduction: Obturator lymph nodes and external iliac nodes are the most common lymph nodes involved in carcinoma endometrium. Less than 5% of the cases with endometrial cancer present as stage IV disease with inguinal lymph node metastasis being 0.38%. Case Report: We report a case of 62 year-old female, post-operative case of ca endometrium with left inguinal swelling since 3 months. MRI of the pelvis revealed 39mm*28mm*24mm nodular subcutaneous lesion in the left inguinal region. Biopsy from the mass reported as cases reported so far. Due to rarity of this scenario, the impact of inguinal LND followed by Post-Operative Radiation Therapy (PORT) in addition to hormonal therapy on the survival in these patients is not well known. Further studies need to be carried out before we can standardise the management in such cases Conclusion: Inguinal lymph node metastasis as a delayed site of occurrence in a case of endometrial carcinoma is a rare phenomenon. However the efficacy of inguinal lymph node dissection with post-operative radiation and adjuvant hormonal treatment in terms of survival benefit metastatic adenocarcinoma with the origin from needs further assessment. endometrium. The patient underwent superficial and deep inguinal lymph node dissection. Histo-pathology reported as metastatic carcinoma with peri nodal infiltration. Immunohistochemistry were positive for CK7, PAX-8, Oestrogen and progesterone receptor Discussion: The risk of recurrence in low grade endometrial cancer is less than 3% with majority of them Keywords: Endometrial carcinoma, Inguinal lymph node metastasis. Introduction: Endometrial cancer is the most common gynaecological malignancy with an incidence of 1 in 40,000 [1,2]. Metastatic spread in endometrial cancer is quiet predictable initially through lymphatics followed by hematogenous and direct spread. The risk of recurrence in occurring in the first 3 years. Inguinal lymph node early stage disease (International Federation of metastasis in early endometrial cancer is rare with five Gynaecology and Obstetrics (FIGO I and II) is between 3- Page 309 Corresponding Author: Dr. Nitesh. R. Maurya, Volume 3 Issue - 5, Page No
2 15% [3,4]. Of these that recur, 76-87% of cases occur within the first 3 years after initial treatment [5]. The most common site of recurrence is the vaginal vault and the pelvis [2]. Obturator lymph nodes and external iliac nodes are the most common lymph nodes involved in carcinoma endometrium [6]. This is followed by internal iliac, common iliac and paraaortic nodes in advanced cases. Less than 5% of the cases with endometrial cancer present as stage IV disease with inguinal lymph node metastasis being 0.38% [7,9]. We report a case of 62 year old female a known case of endometroid adenocarcinoma FIGO 1A 1 Grade 2 presenting to us as initial delayed site metastasis in the inguinal region 7 years post-surgery. Case Report: A 62 year old female was operated for Ca endometrium 7 years back. She underwent Total Abdominal Hysterectomy with Bilateral Salphingooophorectomy (TAH+BSO) with pelvic lymph node sampling. Histo-pathology reported as endometroid adenocarcinoma, 2.5cms*3cms mass in the posterior wall, grade 2 with less than 50% myometrial invasion. 14 and 17 lymph nodes were harvested on right and left side respectively and they were negative. Patient was not advised any adjuvant treatment and kept on regular follow up. Seven years post-surgery she reported to the outpatient department with left inguinal swelling since 3 months. Ultrasonography of the pelvis revealed a 35mm*28mm enlarged lymph node in the left inguinal region. MRI of the pelvis revealed 39mm*28mm*24mm nodular subcutaneous lesion in the left inguinal region. It was hypo-intense on T1(Image1A), hyper-intense on T2(Image1B) and showed homogenous enhancement. Positron emission tomography (PET) imaging showed left inguinal node with standardised uptake volume (SUV max) There was no evidence of metastasis elsewhere. Trucut biopsy from the left inguinal mass reported as metastatic adenocarcinoma with the origin from endometrium. The tumour cells were positive for CK-7 and PAX-8. The patient underwent superficial and deep inguinal lymph node dissection (Image2). Histo-pathology reported as metastatic carcinoma with peri nodal infiltration. Immunohistochemistry were positive for CK- 7, PAX-8, Oestrogen receptor and progesterone receptor. Her case was discussed in multidisciplinary tumour board meeting and a decision to start adjuvant radiation and hormonal therapy was made. Patient refused radiation thaerapy and is currently on hormonal therapy on follow up. Discussion: Endometrial cancer is the most common gynaecological malignancy with an incidence of 1 in 40,000 [1]. Of the many histological types, endometroid adenocarcinoma is the most common histological subtype present. Endometrial cancer is staged surgically and classified according to the FIGO staging classification. FIGO stage I represent cancer confined to the body of the uterus. Further sub-classification depends on the dept of myometrial invasion. Stage IA represents <50% myometrial invasion while stage IB represents more than 50% myometrial invasion [2]. Our patient was staged IA as there was less than 50% myometrial invasion. Treatment of choice for stage IA disease is total abdominal hysterectomy with bilateral salphingo-oophorectomy with or without radiation. There are several risk factors identified for recurrence in early stage endometrial carcinoma which include histology grade, depth of myometrial invasion and age. Depending on these risk factors patients are categorised as low risk(histology grade 1 and 2, <50% myometrial invasion and age <50 years) and high risk for recurrence (grade 3, >50% myometrial invasion, age >60 years) [1]. National Comprehensive Cancer Network (NCCN) guidelines for endometrial cancer state adjuvant radiation therapy to be considered if two or more risk factors are present, although recent Page310
3 studies have not shown an overall survival benefit with this approach. Our patient falls in the low risk group and hence she was advised no further adjuvant therapy and kept on a regular follow-up. The risk of recurrence in low grade endometrial cancer is less than 3-15% with majority of them occurring in the first 3 years [3-5,8]. The most common site for endometrial recurrence are vaginal vault and pelvis [9]. Inguinal Lymph node metastasis in early endometrial cancer is very rare with five cases being reported so far in English literature (Table1). The precise mechanism of inguinal lymph node metastasis is still unknown. As per FIGO staging system, inguinal nodes metastasis from endometrial carcinoma are classified as FIGO stage IVB, and is regarded as a systemic disease. Immunohistochemistry is as an important diagnostic tool in identifying the site of tumour origin in cases of difficult pathological differential diagnosis. Tumours of Mullerian origin are positive for PAX-8 [14,15]. In our case IHC was positive for PAX-8 thus establishing the metastatic origin of inguinal lymph node mass. PE-CT scan serves as an important imaging diagnostic tool in assessing treatment response as well as monitoring relapse [16]. There are ongoing trials assessing the utility of PET-CT in monitoring treatment response. PET-CT was performed at baseline and at 2 weeks and 6 weeks following initial treatment. Changes in total lesion glycolysis(tlg) after 2 weeks predicted partial response and a rise in SUV max between 2 weeks and 6 weeks predicted progression and was associated with worse progression free survival. In addition, early response evaluation with FDG PET/CT was useful in predicting subsequent radiological PR and progression disease [16]. Given the limited reported data on this issue, more investigation is needed. There are guidelines suggesting the use of PET-CT as compared to MRI and CECT for relapse assessment in terms of sensitivity, specificity and accuracy [16,17]. Due to rarity of this scenario, the impact of inguinal LND followed by Post-Operative Radiation Therapy (PORT) in addition to hormonal therapy on the survival in these patients is not well known. Further studies need to be carried out before we can standardise the management in such cases. Conclusion: Inguinal lymph node metastasis as a delayed site of occurrence in a case of endometrial carcinoma is a rare phenomenon. However the efficacy of inguinal lymph node dissection with post-operative radiation and adjuvant hormonal treatment in terms of survival benefit needs further assessment. References 1. Jeffery. A. Hubers and Anurag Soni. A rare Case of Endometrial Cancer Metastatic to the Sigmoid Colon and Small Bowel. Case Rep Gastrointest Med. 2017; 2017: FIGO Committee on Gynecologic Oncology. FIGO staging for carcinoma of the vulva, cervix and corpus uteri. International Journal of Gynecology & Obstetrics. 2014;125(2): Raphael Yechieli, Jared R. Robbins, Daniel Schultz, Adnan Munkarah, Mohamed A. Elshaikh. Vaginal Recurrence more than 17 years after hysterectomy and adjuvant treatment for uterine carcinoma with successful salvage brachytherapy: A Case Report. Case Rep Oncol 2011; 4: Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH: Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol 2007; CD Creutzberg CL, van Putten WLJ, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen- Banasik E, Beerman H, van Lent M; PORTEC Study Group: Survival after relapse in patients with Page311
4 endometrial cancer: results from a randomized trial. Gynecol Oncol 2003;89: Jobo T, Sato R, aria T, Tamura T, Watanabe J, Kuramoto H. Lymph node pathway in spread of endometrial cancer. Eur J Gynaecol Oncol 2005;26(2): S Scholz, Heinz & Lax, Sigurd & Petru, Edgar & Benedicic, Christoph & Winter, Raimund. (2002). Inguinal lymph node metastasis as the presenting symptom of endometrial cancer: A case report. Anticancer research Ayelet Shai, Enachem Ben Shachar and LiatApel Sarid. Late Recurrence of Endometrial Carcinoma mimicking Primary Colon Cancer- Case Report and Review of Literature. J Cancer Clin Trials 2017, 2:1 9. Shomaila Amir M. Akbar, Mutahir A. Tunio, Wafa Alshakweer, et al. Inguinal lymph node presenting as the delayed site of metastasis in early stage endometrial carcinoma: Case report. International Journal of Surgery Case Reports, 32 (2017), J.A. Carr, P.A. Schoon, K.Y. Look, An atypical recurrence of endometrial carcinoma following estrogen replacement therapy, Gynecol. Oncol. 60 (1996) F. Ortac, S. Taskın, Inguinal recurrence of early stage endometrial cancer after 7 months of surgical staging: the role of PET-CT in diagnosis and management, Int. J. Clin. Oncol. 17 (2012) B.L. Seagle, D.M. Cleason, R. Samuelson, S. Shahabi, Inguinal node metastasis of low-grade endometrial endometrioid adenocarcinoma in a morbidly obese patient, Conn. Med. 79 (2015) Y.C. Wu, S.L. Huang, C.K. Chuang, S.M. Jung, C.H. Lai, Successful salvage treatment of recurrent endometrial cancer with bulky central tumor and extensive lymph node metastasis. A case report, Eur. J. Gynaecol. Oncol. 25 (2004) K. Miura, K. Ishida, W. Fujibuchi et al., Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database, Surgery Today,vol.42, no.6, pp , A. H. Brunner, P. Riss, G. Heinze, E. Meltzow, and H. Brust- mann, Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53, International Journal of Gynaecological Pathology, Vol.30, no.6, , Alessandra Musto, Gaia Grasetto, Maria Cristina, et al. Role of 18F-FDG PET/CT in the carcinoma of uterus: A review of literatur. Yonseni Med J Nov 1; 55(6): Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO Clinical Practise Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24(Suppl 6): vi33- vi38. Page312
5 Figure and Tables Figure 1: MRI of the pelvis shows 39*28*24 mm nodular subcutaneous lesion (a) hypointense lesion on T1 (b) hyperintense on T2. Figure 2: Surgical specimen of left inguinal lymph node dissection. Page313
Staging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer
THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT
More informationCervical Cancer: 2018 FIGO Staging
Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford
More informationNew Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%
Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%
More informationFDG-PET/CT in Gynaecologic Cancers
Friday, August 31, 2012 Session 6, 9:00-9:30 FDG-PET/CT in Gynaecologic Cancers (Uterine) cervical cancer Endometrial cancer & Uterine sarcomas Ovarian cancer Little mermaid (Edvard Eriksen 1913) honoring
More informationIndex. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
More informationRelapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following
More informationCitation for published version (APA): van Kruchten, M. (2015). Molecular imaging of estrogen receptors [Groningen]: University of Groningen
University of Groningen Molecular imaging of estrogen receptors van Kruchten, Michel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationProposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram
Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with
More informationPre-operative Evaluation and Implications
Pre-operative Evaluation and Implications Michal Zikan Gynecologic Oncology Center Charles University in Prague, First Faculty of Medicine No recommendation for screening of EC (HNPCC annual biopsies starting
More informationEndometrial Cancer. Incidence. Types 3/25/2019
Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationStaging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion
5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
More informationSurvival analysis of endometrial cancer patients with cervical stromal involvement
Original Article J Gynecol Oncol Vol. 25, No. 2:105-110 pissn 2005-0380 eissn 2005-0399 Survival analysis of endometrial cancer patients with cervical stromal involvement Jonathan E. Frandsen 1, William
More informationTreatment of Vaginal Recurrences in Endometrial Carcinoma by High-dose-rate Brachytherapy
Treatment of Vaginal Recurrences in Endometrial Carcinoma by High-dose-rate Brachytherapy BENGT SORBE 1 and KARIN SÖDERSTRÖM 2 1 Department of Oncology, University Hospital, Örebro, Sweden; 2 Department
More informationProf. Dr. Aydın ÖZSARAN
Prof. Dr. Aydın ÖZSARAN Adenocarcinomas of the endometrium Most common gynecologic malignancy in developed countries Second most common in developing countries. Adenocarcinomas, grade 1 and 2 endometrioid
More informationENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media
For mass reproduction, content licensing and permissions contact Dowden Health Media. UPDATE ENDOMETRIAL CANCER Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial
More informationCase 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst
Gynaecology Case Presentation Organ Imaging 2016 University of Toronto Sarah Johnson 39 year old female Clinical history: Assess right ovarian cyst Clinically diagnosed endometriosis Started fertility
More informationsurgical staging g in early endometrial cancer
Risk adapted d approach to surgical staging g in early endometrial cancer Leon Massuger University Medical Centre St Radboud Nijmegen, The Netherlands Doing nodes Yes Yes Yes No No No 1957---------------------------
More informationPET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp
PET/CT in Gynaecological Cancers Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp Cervix cancer Outline of this talk Initial staging Treatment monitoring/guidance
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More informationJMSCR Vol 05 Issue 06 Page June 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i6.29 MRI in Clinically Suspected Uterine and
More informationViews and counter views The role of pelvic and para-aortic lymph node dissection in the surgical treatment of endometrial cancer: a view from the USA
The Obstetrician & Gynaecologist 10.1576/toag.11.3.199.27505 http://onlinetog.org 2009;11:199 204 Views and counter views Views and counter views The role of pelvic and para-aortic lymph node dissection
More informationRadiation Therapy in Early Endometrial Cancers: Con
Radiation Therapy in Early Endometrial Cancers: Con 106 Jamie N. Bakkum-Gamez, MD Andrea Mariani, MD Karl C. Podratz, MD, PhD Introduction Endometrial cancer (EC) represents a heterogeneous spectrum of
More informationPost operative Radiotherapy in Carcinoma Endometrium - KMIO Experience (A Retrospective Study)
Post operative Radiotherapy in Carcinoma Endometrium - KMIO Experience (A Retrospective Study) Sridhar.P, M.D. 1, Sruthi.K, M.D. 2, Naveen.T, M.D. 3, Siddanna.R.P, M.D. 4 Department of Radiation Oncology,
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationImpact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma
Hou et al. / Cancer Cell Research 3 (2014) 65-69 Cancer Cell Research Available at http:// http://www.cancercellresearch.org/ ISSN 2161-2609 Impact of Surgery Extent on Survival and Recurrence Rate of
More informationCase Scenario 1. History
History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family
More informationC ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)
C ORPUS UTERI C ARCINOMA STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery Tis * T1 I T1a IA NX N0 N1 N2
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationDisclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None
What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department
More information2016 Uterine Cancer Annual Report
2016 Uterine Cancer Annual Report Overview At Carolinas HealthCare System s Levine Cancer Institute, we offer comprehensive care focused on using the latest technology and innovative techniques in the
More informationManagement of Endometrial Hyperplasia
Management of Endometrial Hyperplasia I have nothing to disclose. Stefanie M. Ueda, M.D. Assistant Clinical Professor UCSF Division of Gynecologic Oncology Female Malignancies in the United States New
More informationUnusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma
49 Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma Loredana Miglietta a Maria Angela Parodi b Luciano Canobbio b Luca Anselmi c a Medical
More informationC ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)
CLINICAL C ORPUS UTERI C ARCINOMA STAGING FORM PATHOLOGIC Extent of disease before S TAGE C ATEGORY D EFINITIONS Extent of disease through any treatment completion of definitive surgery y clinical staging
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix
THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationICRT รศ.พญ.เยาวล กษณ ชาญศ ลป
ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป Brachytherapy การร กษาด วยร งส ระยะใกล Insertion การสอดใส แร Implantation การฝ งแร Surface application การวางแร physical benefit of brachytherapy - very high dose of radiation
More informationAdjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: A multi-institutional analysis of 608 women
Gynecologic Oncology 103 (2006) 661 666 www.elsevier.com/locate/ygyno Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: A multi-institutional analysis of 608 women O. Kenneth
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationVaginal intraepithelial neoplasia
Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the
More informationEndometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines
Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology
More informationPlease complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE
Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with
More informationManagement of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D.
Management of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
More informationLymphovascular Invasion Is a Significant Predictor for Distant Recurrence in Patients With Early-Stage Endometrial Endometrioid Adenocarcinoma
Anatomic Pathology / LVI in Endometrial Cancer Lymphovascular Invasion Is a Significant Predictor for Distant Recurrence in Patients With Early-Stage Endometrial Endometrioid Adenocarcinoma Sharon Nofech-Mozes,
More informationLymphovascular space invasion in early-stage endometrial cancer: adjuvant treatment and patterns of recurrence
Southern 10 African African Journal Journal of Gynaecological of Gynaecological Oncology Oncology 2016; 8(1):10-15 2016; 1(1):1 6 http://dx.doi.org/10.1080/20742835.2016.1175708 Open Access article article
More informationShina Oranratanaphan, Tarinee Manchana*, Nakarin Sirisabya
Comparison of Synchronous Endometrial and Ovarian Cancers versus Primary with Metastasis RESEARCH COMMUNICATION Clinicopathologic Variables and Survival Comparison of Patients with Synchronous Endometrial
More information2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA
2009 USCAP Gyn Pathology Evening Session Case #3 Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA rzaino@psu.edu Clinical history Middle aged woman with an exophytic mass of
More informationCurrent staging of endometrial carcinoma with MR imaging
Current staging of endometrial carcinoma with MR imaging Poster No.: C-1436 Congress: ECR 2015 Type: Educational Exhibit Authors: M. Magalhaes, H. Donato, C. B. Marques, P. Gomes, F. Caseiro Alves; Coimbra/PT
More informationIntra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer
Arch Gynecol Obstet (2012) 285:811 816 DOI 10.1007/s00404-011-2038-z GYNECOLOGIC ONCOLOGY Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical
More informationThe International Federation of Gynecology and Obstetrics (FIGO) updated the staging
Continuing Education Column Revised FIGO Staging System Hee Sug Ryu, MD Department of Obstetrics and Gynecology, Ajou University School of Medicine E - mail : hsryu@ajou.ac.kr J Korean Med Assoc 2010;
More informationUPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER
UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER Susan Davidson, MD Professor Department of Obstetrics and Gynecology Division of Gynecologic Oncology University of Colorado- Denver Anatomy Review
More informationUTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS
Review Journal of Translational Medicine and Research, volume 19, no. 1-2, 2014 UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS N. Bacalbaæa 1, A. Traistaru 2, I. Bãlescu 3 1 Carol Davila University of Medicine
More informationGynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0)
Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0) ** VALID ON DATE OF PRINTING ONLY all guidelines available on the Strategic Clinical Network website : GMLSC SCN Date first published
More informationJanjira Petsuksiri, M.D
GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors
More informationAn Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review of the Literature
Archives of Clinical and Medical Case Reports doi: 10.26502/acmcr.9655003 Volume 1, Issue 1 Case Report An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review
More informationENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre)
ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) Source: UpToDate 2017, ASCO/CCO/Alberta provincial guidelines, NCCN Reviewed by: Dr. Sarah Glaze (Gynecologic
More informationPort-Site Metastases After Robotic Surgery for Gynecologic Malignancy
SCIENTIFIC PAPER Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy Noah Rindos, MD, Christine L. Curry, MD, PhD, Rami Tabbarah, MD, Valena Wright, MD ABSTRACT Background and Objectives:
More informationSpectrum of FDG PET/CT Findings of Uterine Tumors
Nuclear Medicine and Molecular Imaging Pictorial Essay Kitajima et al. FDG PET/CT of Uterine Tumors Nuclear Medicine and Molecular Imaging Pictorial Essay Downloaded from www.ajronline.org by 37.44.205.17
More informationPORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:
May 2016 Randomisation Checklist Form 1, page 1 of 2 Patient seqnr. Age at inclusion (years) Hospital: Eligible patients should be registered and randomised via the Internet at : https://prod.tenalea.net/fs4/dm/delogin.aspx?refererpath=dehome.aspx
More informationArticle begins on next page
Scalp metastasis as a presenting symptom of Cervical Squamous Cell Carcinoma Rutgers University has made this article freely available. Please share how this access benefits you. Your story matters. [https://rucore.libraries.rutgers.edu/rutgers-lib/50623/story/]
More informationVagina. 1. Introduction. 1.1 General Information and Aetiology
Vagina 1. Introduction 1.1 General Information and Aetiology The vagina is part of internal female reproductive system. It is an elastic, muscular tube that connects the outside of the body to the cervix.
More informationAbscopal Effect of Radiation on Toruliform Para-aortic Lymph Node Metastases of Advanced Uterine Cervical Carcinoma A Case Report
Abscopal Effect of Radiation on Toruliform Para-aortic Lymph Node Metastases of Advanced Uterine Cervical Carcinoma A Case Report MAMIKO TAKAYA 1, YUZURU NIIBE 1, SHINPEI TSUNODA 2, TOSHIKO JOBO 2, MANAMI
More informationOriginal Date: June 2013 ENDOMETRIAL CANCER
National Imaging Associates, Inc. Clinical guidelines Original Date: June 2013 ENDOMETRIAL CANCER Page 1 of 6 Radiation Oncology Last Review Date: July 2018 Guideline Number: NIA_CG_129 Last Revised Date:
More informationMRI in Cervix and Endometrial Cancer
28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK Objectives Cervix and endometrial
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationSLN Mapping in Cervical Cancer. Memorial Sloan Kettering Cancer Center New York, USA
Lead Grou p Log SLN Mapping in Cervical Cancer Nadeem R. Abu-Rustum, M.D. Memorial Sloan Kettering Cancer Center New York, USA Conflict of Interest Disclosure Nadeem R. Abu-Rustum, M.D. I have no financial
More informationENDOMETRIAL CANCER: A GUIDE FOR PATIENTS
ENDOMETRIAL CANCER: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by Reliable Cancer Therapies (RCT) as a service to patients,
More informationPET/CT for the evaluation of gynecological
PET/CT for the evaluation of gynecological cancer Gynecological cancer Barcelona, September 16 th 2018 Dr. Pilar Paredes, MD, PhD Nuclear Medicine Department Hospital Clínic Barcelona (Spain) PET/CT in
More informationCervical Cancer 3/25/2019. Abnormal vaginal bleeding
Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms
More informationInvasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous
Note: If available, clinical trials should be considered as preferred treatment options for eligible patients (www.mdanderson.org/gynonctrials). Other co-morbidities are taken into consideration prior
More informationBaseline risk of recurrence in stage I II endometrial carcinoma
J Gynecol Oncol. 2018 Jan;29(1):e9 pissn 2005-0380 eissn 2005-0399 Original Article Baseline risk of recurrence in stage I II endometrial carcinoma Shinsuke Sasada, 1,2 Mayu Yunokawa, 1,3 Yae Takehara,
More informationThe Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD
The Role of Radiation in the Management of Gynecologic Cancers Scott Glaser, MD Nothing to disclose DISCLOSURE Outline The role of radiation in: Endometrial Cancer Adjuvant Medically inoperable Cervical
More informationSCBT.MR MRI of Uterine Malignancy. Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC
2 0 1 6 SCBT.MR MRI of Uterine Malignancy Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC aschers@gunet.georgetown.edu MUST READS Sala E, et al. The added role of
More informationGynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy
Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,
More informationPet Scan And Gynaecological Malignancies: Hospital Sultanah Bahiyah Experience
ORIGINAL ARTICLE Pet Scan And Gynaecological Malignancies: Hospital Sultanah Bahiyah Experience T Shahila, MMED (O&G), M N Rushdan, MMED (O&G) Gynaecological Oncology Unit, Department of Obstetrics & Gynaecology,
More informationImaging of endometrial and cervical cancer
Insights Imaging (2010) 1:309 328 DOI 10.1007/s13244-010-0042-7 REVIEW Imaging of endometrial and cervical cancer Shilpa Patel & Sidath H. Liyanage & Anju Sahdev & Andrea G. Rockall & Rodney H. Reznek
More informationNewton Wellesley Hospital 2013
Newton Wellesley Hospital 20 Standard 4.6 Assessment and Evaluation of Treatment Planning Endometrial Cancer Each year a physician member of the cancer committee conducts a study to ensure that diagnostic
More informationFERTILITY SPARING IN ENDOMETRIAL CANCER
FERTILITY SPARING IN ENDOMETRIAL CANCER Prof. Dr. Bülent Özçelik Erciyes University Medical Faculty Department of Obstetrics and Gynecology Gynecologic Oncology Unit Endometrial Cancer Most frequent gynecologic
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationPrognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis
NJOG 2009 June-July; 4 (1): 19-24 Prognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis Eliza Shrestha 1, Xiong Ying 1,2, Liang Li-Zhi 1,2, Zheng Min 1,2,
More informationControversies in the management of early endometrial carcinoma: an update
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Reddi PR et al. Int J Reprod Contracept Obstet Gynecol. 2017 Jun;6(6):2124-2131 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172301
More informationPET imaging of cancer metabolism is commonly performed with F18
PCRI Insights, August 2012, Vol. 15: No. 3 Carbon-11-Acetate PET/CT Imaging in Prostate Cancer Fabio Almeida, M.D. Medical Director, Arizona Molecular Imaging Center - Phoenix PET imaging of cancer metabolism
More informationRochester Minnesota Mayo Clinic
Are There Still Indications for Lymphadenectomy in Endometrial Cancer? A Mariani Mayo Clinic Rochester - MN USA Rochester Minnesota Mayo Clinic 1 Endometrial Cancer Lymphadenectomy Yes or No? Endometrial
More informationStudy Title The SACS trial - Phase II Study of Adjuvant Therapy in CarcinoSarcoma of the Uterus
Study Title The SACS trial - Phase II Study of Adjuvant Therapy in CarcinoSarcoma of the Uterus Investigators Dr Bronwyn King, Peter MacCallum Cancer Centre Dr Linda Mileshkin, Peter MacCallum Cancer Centre
More informationAdjuvant Radiotherapy in Endometrial Carcinoma David T. Shaeffer and Marcus E. Randall. doi: /theoncologist
Adjuvant Radiotherapy in Endometrial Carcinoma David T. Shaeffer and Marcus E. Randall The Oncologist 2005, 10:623-631. doi: 10.1634/theoncologist.10-8-623 The online version of this article, along with
More informationARRO Case: Early-stage Endometrial Cancer
ARRO Case: Early-stage Endometrial Cancer Ankit Modh, MD (PGY-4) Faculty Advisor: Mohamed A Elshaikh, MD Department of Radiation Oncology Henry Ford Cancer Institute Case Presentation 70 y/o African American
More informationCervical cancer presentation
Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000
More informationWendy L Frankel. Chair and Distinguished Professor
1 Wendy L Frankel Chair and Distinguished Professor Case 1 59 y/o woman Abdominal pain No personal or family history of cancer History of colon polyps Colonoscopy Polypoid rectosigmoid mass Biopsy 3 4
More information3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates
J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs
More informationSarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru
Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma
More informationEndometrial cancer. Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology.
Endometrial cancer Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology dr.mate.szabolcs@gmail.com Epidemiology Developing countries Cervical cancer is the most common gyn. malignant tumor
More informationMonica Dandapani, 1 Brandon-Luke L. Seagle, 1 Amer Abdullah, 1 Bryce Hatfield, 2 Robert Samuelson, 1 and Shohreh Shahabi 3. 1.
Hindawi Publishing Corporation Case Reports in Obstetrics and Gynecology Volume 2015, Article ID 950373, 5 pages http://dx.doi.org/10.1155/2015/950373 Case Report Metastatic Uterine Leiomyosarcoma Involving
More informationThe new FIGO classification in endometrial carcinoma
The new FIGO classification in endometrial carcinoma Poster No.: C-1073 Congress: ECR 2012 Type: Educational Exhibit Authors: A. IGLESIAS CASTAÑON, M. Arias Gonzales, J. Mañas Uxó, 1 2 1 2 2 2 B. NIETO
More information17 th ESO-ESMO Masterclass in clinical Oncology
17 th ESO-ESMO Masterclass in clinical Oncology Cervical and endometrial Cancer Cristiana Sessa IOSI Bellinzona, Switzerland Berlin, March 28 th, 2018 Presenter Disclosures None Cervical Cancer Estimated
More informationA phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008
A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 NCT02432365 Chyong-Huey Lai, MD On behalf of Principal investigator
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR Last Revision Date July 2015 1 Site Group: Gynecologic Cancer Vulvar Author: Dr. Stephane Laframboise 1. INTRODUCTION
More information